Literature DB >> 11680581

Phospholipid alterations in hepatocyte membranes and transporter protein changes in cholestatic rat model.

H Hyogo1, S Tazuma, T Nishioka, H Ochi, A Yamaguchi, Y Numata, K Kanno, M Sakomoto, Y Asamoto, K Tsuboi, K Nakai, S Yasumiba, Y Sunami, G Kajiyama.   

Abstract

Biliary components are transported by hepatic adenosine triphosphate-binding cassette (ABC) transporters that are located in canalicular membranes. Physiological transporter function is related to membrane fluidity, which is modulated by the phospholipid composition of the lipid bilayer. We hypothesized that cholestasis may alter transporter function by modifying phospholipid species to protect the cell from cholestatic damage. Therefore, we examined the expression of ABC transport proteins and their mRNA levels in canalicular membrane vesicles isolated from rat liver 6 hr or three days after bile duct ligation. Membrane lipid composition and membrane fluidity of both sinusoidal and canalicular membrane vesicles were also examined. By 6 hr after bile duct ligation, we found a clear increase of mdr2 and bsep mRNA. These changes were associated with an increase of mdr-Pgp and with a clear decrease of mrp2 protein, and small decrease of bsep protein. In addition, mdrlb mRNA showed a strong increase by three days after bile duct ligation. Canalicular membrane fluidity decreased in a marked time-dependent manner, whereas sinusoidal membranes showed biphasic changes: increased fluidity at 6 hr and a decrease at three days. These changes were closely related to the changes of membrane lipid constitution; the saturated/unsaturated fatty acid ratio increased for phosphatidylcholine in canalicular membrane and the reverse occurred in sinusoidal membrane, and those for sphingomyelin showed the opposite pattern. We conclude that cholestasis causes modulation of ABC transporters as well as that of the lipid constitution in lipid bilayer. These may confer cytoprotective resistance to hepatocytes against cholestatic stress.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11680581     DOI: 10.1023/a:1011934108920

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  43 in total

1.  Characterization of rat hepatocyte plasma membrane domains by monoclonal antibodies.

Authors:  M Maurice; A M Durand-Schneider; M Garbarz; G Feldmann
Journal:  Eur J Cell Biol       Date:  1985-11       Impact factor: 4.492

2.  Effect of obstructive cholestasis on membrane traffic and domain-specific expression of plasma membrane proteins in rat liver parenchymal cells.

Authors:  B Stieger; P J Meier; L Landmann
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425

Review 3.  Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport.

Authors:  R P Oude Elferink; D K Meijer; F Kuipers; P L Jansen; A K Groen; G M Groothuis
Journal:  Biochim Biophys Acta       Date:  1995-07-17

4.  Differential expression of multidrug resistance (mdr) and canalicular multispecific organic anion transporter (cMOAT) genes following extrahepatic biliary obstruction in rats.

Authors:  T Kagawa; N Watanabe; M Sato; A Nakano; Y Nishizaki; K Hosoi; S Takashimizu; J Uchiyama; M Kimura; S Matsuzaki
Journal:  Biochem Mol Biol Int       Date:  1998-03

Review 5.  Current problems in diagnosis of biliary disease and cholestasis.

Authors:  V J Desmet
Journal:  Semin Liver Dis       Date:  1986-08       Impact factor: 6.115

6.  MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine.

Authors:  A van Helvoort; A J Smith; H Sprong; I Fritzsche; A H Schinkel; P Borst; G van Meer
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

7.  Taurocholate transport by rat liver sinusoidal membrane vesicles: evidence of sodium cotransport.

Authors:  M Inoue; R Kinne; T Tran; I M Arias
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

8.  Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (-/-) mice.

Authors:  A J Smith; J M de Vree; R Ottenhoff; R P Oude Elferink; A H Schinkel; P Borst
Journal:  Hepatology       Date:  1998-08       Impact factor: 17.425

9.  Simultaneous microanalysis of biliary cholesterol, bile acids and fatty acids in lecithin using capillary column gas chromatography: an advantage to assess bile lithogenecity.

Authors:  S Tazuma; S Hatsushika; G Yamashita; N Aihara; M Sasaki; K Horikawa; Y Yamashita; K Teramen; H Ochi; N Hirano
Journal:  J Chromatogr B Biomed Appl       Date:  1994-02-18

10.  Identification of rat hepatocyte plasma membrane proteins using monoclonal antibodies.

Authors:  A L Hubbard; J R Bartles; L T Braiterman
Journal:  J Cell Biol       Date:  1985-04       Impact factor: 10.539

View more
  4 in total

1.  Hepatoprotection in bile duct ligated mice mediated by darbepoetin-α is not caused by changes in hepatobiliary transporter expression.

Authors:  Christian Eipel; Elena Menschikow; Michael Sigal; Angela Kuhla; Kerstin Abshagen; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2012-11-20

Review 2.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

Review 3.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

4.  Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma.

Authors:  Paul R Territo; Mary Maluccio; Amanda A Riley; Brian P McCarthy; James Fletcher; Mark Tann; Romil Saxena; Nicholas J Skill
Journal:  BMC Med Imaging       Date:  2015-05-16       Impact factor: 1.930

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.